Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.